Record Details

Computational screening for new inhibitors of M. tuberculosis mycolyltransferases antigen 85 group of proteins as potential drug targets

EPrints@IICB

View Archive Info
 
 
Field Value
 
Title Computational screening for new inhibitors of M.
tuberculosis mycolyltransferases antigen 85 group of
proteins as potential drug targets
 
Creator Gahoi, Shachi
Mandal, Rahul Shubhra
Ivanisenko, Nikita
Shrivastava, Priyanka
Jain, Sriyans
Singha, Ashish Kumar
Raghunandanan, Muthukurrusi Varieth
Kanchan, Swarna
Taneja, Bhupesh
Mandal, Chhabinath
Ivanisenko, Vladimir A
Kumar, Rita
Kumar, Anil
Ramachandran, Srinivasan
 
Subject Molecular & Human Genetics
 
Description The group of antigen 85 proteins of Mycobacterium tuberculosis is responsible for converting trehalose monomycolate to
trehalose dimycolate, which contributes to cell wall stability. Here, we have used a serial enrichment approach to identify
new potential inhibitors by searching the libraries of compounds using both 2D atom pair descriptors and binary fingerprints
followed by molecular docking. Three different docking softwares AutoDock, GOLD, and LigandFit were used for
docking calculations. In addition, we applied the criteria of selecting compounds with binding efficiency close to the starting
known inhibitor and showing potential to form hydrogen bonds with the active site amino acid residues. The starting
inhibitor was ethyl-3-phenoxybenzyl-butylphosphonate, which had IC50 value of 2.0 μM in mycolyltransferase inhibition
assay. Our search from more than 34 million compounds from public libraries yielded 49 compounds. Subsequently, selection
was restricted to compounds conforming to the Lipinski rule of five and exhibiting hydrogen bonding to any of the
amino acid residues in the active site pocket of all three proteins of antigen 85A, 85B, and 85C. Finally, we selected those
ligands which were ranked top in the table with other known decoys in all the docking results. The compound NIH415032
from tuberculosis antimicrobial acquisition and coordinating facility was further examined using molecular dynamics simulations
for 10 ns. These results showed that the binding is stable, although some of the hydrogen bond atom pairs varied
through the course of simulation. The NIH415032 has antitubercular properties with IC90 at 20 μg/ml (53.023 μM). These
results will be helpful to the medicinal chemists for developing new antitubercular molecules for testing
 
Date 2013
 
Type Article
PeerReviewed
 
Format application/pdf
 
Identifier http://www.eprints.iicb.res.in/1968/1/JOURNAL_OF_BIOMOLECULAR_STRUCTURE_%26_DYNAMICS__Volume_31_(_1)__Special_Issue_SI___Pages_30%2D43_;2013[149].pdf
Gahoi, Shachi and Mandal, Rahul Shubhra and Ivanisenko, Nikita and Shrivastava, Priyanka and Jain, Sriyans and Singha, Ashish Kumar and Raghunandanan, Muthukurrusi Varieth and Kanchan, Swarna and Taneja, Bhupesh and Mandal, Chhabinath and Ivanisenko, Vladimir A and Kumar, Rita and Kumar, Anil and Ramachandran, Srinivasan (2013) Computational screening for new inhibitors of M. tuberculosis mycolyltransferases antigen 85 group of proteins as potential drug targets. Journal of Biomolecular Structure and Dynamics, 31 (1). pp. 30-43.
 
Relation http://dx.doi.org/10.1080/07391102.2012.691343
http://www.eprints.iicb.res.in/1968/